Travaux scientifiques

Doç. Dr. Muhammed Mustafa Atcı

104 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil
  1. The Predictive Value of Baseline Volumetric PET/CT Parameters on Treatment Response and Prognosis in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy

    Journal of Gastrointestinal Cancer, 2021

    DOI 10.1007/s12029-021-00608-y PMID 33651265 11 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  2. Survival and Prognostic Factors in Limited-stage Small-cell Lung Cancer

    Journal of College of Physicians And Surgeons Pakistan, 2021

    DOI 10.29271/jcpsp.2021.12.1433 PMID 34794283 7 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  3. The Prognostic Value of Postoperative Lymph Node Ratio in Gastric Adenocarcinoma Patients Treated With Neoadjuvant Chemotherapy

    Cureus, 2021

    DOI 10.7759/cureus.14639 PMID 34046274 5 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  4. Factors affecting survival in retroperitoneal sarcomas treated with upfront surgery: A real-world study by Turkish Oncology Group

    Van Yüzüncü Yıl University Academic Data Management System, 2021

    DOI 10.4999/uhod.215190 2 citations (OpenAlex) Source : OpenAlex

  5. Effect of type 2 diabetes mellitus on survival in metastatic pancreatic cancer

    Journal of Surgery and Medicine, 2021

    DOI 10.28982/josam.840948 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  6. Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study

    Tumori Journal, 2021

    DOI 10.1177/03008916211037739 PMID 34365852 5 citations (Europe PMC) Source : OpenAlex

  7. Impact of Coronaphobia on Treatment and Follow-Up Compliance of Cancer Patients

    Future Oncology, 2021

    DOI 10.2217/fon-2021-0020 PMID 33880932 4 citations (Europe PMC) Source : OpenAlex

  8. Cetuximab-induced rash is associated with overall survival in patients with recurrent/metastatic squamous cell carcinoma of head and neck

    Cancer Chemotherapy and Pharmacology, 2021

    DOI 10.1007/s00280-021-04328-9 PMID 34312705 1 citation (Europe PMC) Source : OpenAlex

  9. La correlación entre los marcadores tumorales y los hallazgos de Ga-68DOTA-TATE PET/TC en pacientes con cáncer medular de tiroides avanzado

    Revista Española de Medicina Nuclear e Imagen Molecular, 2021

    DOI 10.1016/j.remn.2020.03.012 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  10. Assessment of abuse and related factors in older patients with cancer

    Supportive Care in Cancer, 2021

    DOI 10.1007/s00520-021-06391-7 PMID 34213643 1 citation (Europe PMC) Source : OpenAlex

  11. Predictive Importance of Vitamin D on Response to Neoadjuvant Chemotherapy in Turkish Patients with Locally Advanced Hormone Receptor Positive Breast Cancer

    Eurasian Journal of Medical Investigation, 2021

    DOI 10.14744/ejmi.2021.99947 1 citation (OpenAlex) Source : OpenAlex

  12. Determining the Current Situation of Geriatric Oncology in Turkey: A Survey of Medical Oncologists

    Journal of Oncological Sciences, 2021

    DOI 10.37047/jos.2020-80824 Texte intégral en libre accèsSource : OpenAlex

  13. Tiroid Bezi ve Hastalıklarına Multidisipliner Yaklaşım

    Akademisyen Kitabevi eBooks, 2021

    DOI 10.37609/akya.224 Texte intégral en libre accèsSource : OpenAlex

  14. Assessment of pretreatment albumin-bilirubin grade in pancreatic cancer patients with liver metastasis.

    PubMed, 2020

    PMID 33099936 10 citations (Europe PMC) Source : OpenAlex

  15. The predictive role of metabolic tumor volume on no response to neoadjuvant chemotherapy in patients with breast cancer

    Journal of Oncology Pharmacy Practice, 2020

    DOI 10.1177/1078155219898504 PMID 31955700 3 citations (Europe PMC) Source : OpenAlex

  16. The conversion of RAS status in metastatic colorectal cancer patients after first‐line biological agent treatment

    Colorectal Disease, 2020

    DOI 10.1111/codi.15389 PMID 33002301 3 citations (Europe PMC) Source : OpenAlex

  17. The Effect of Body Mass Index on Treatment Outcomes in Patients with Metastatic Non-Small Cell Lung Cancer Treated with Platinum-Based Therapy

    Nutrition and Cancer, 2020

    DOI 10.1080/01635581.2020.1801774 PMID 32748654 5 citations (Europe PMC) Source : OpenAlex

  18. The correlation between tumor markers and Ga-68 DOTA-TATE PET/CT findings in patients with advanced medullary thyroid cancer

    Revista Española de Medicina Nuclear e Imagen Molecular (English Edition), 2020

    DOI 10.1016/j.remnie.2020.04.005 PMID 33451923 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  19. Factors affecting survival in patients with isolated liver-metastatic colorectal cancer treated with local ablative or surgical treatments for liver metastasis.

    PubMed, 2019

    PMID 31786840 5 citations (Europe PMC) Source : OpenAlex

  20. The evaluation of efficacy and tolerability of gemcitabine vs. capecitabine therapy in the second-line setting for metastatic pancreatic cancer patients with poor performance status

    Journal of Oncological Sciences, 2019

    DOI 10.1016/j.jons.2019.08.003 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  21. D. Ulusal hakemli dergilerde yayımlanan makaleler

    Source : page de profil sur livhospital.com

  22. A. Uluslararası Hakemli Dergilerde Yayımlanan Makaleler

    Source : page de profil sur livhospital.com

  23. Yazılan ulusal/uluslararası kitaplardaki bölümler

    Source : page de profil sur livhospital.com

  24. Atcı Muhammed Mustafa, Akagündüz Baran, ve diğerleri. "The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre study." Journal of Chemotherapy.

    Source : page de profil sur livhospital.com

  25. Hızal Mutlu, Bilgin Burak, ve diğerleri. "Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-smallcell lung cancer patients: a Turkish Oncology Group study." Future Oncology.

    Source : page de profil sur livhospital.com

  26. Özdemir Özlem, Zengel Baha, ve diğerleri. "The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or earlystage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study." Anti-Cancer Drugs.

    Source : page de profil sur livhospital.com

  27. Akagündüz Baran, Demir Metin, Atcı Muhammed Mustafa. "Controlling Nutritional Status (CONUT) Score Is a Prognostic Factor for Patients with Gastric Cancer Treated by Perioperative FLOT." Journal of Gastrointestinal Cancer.

    Source : page de profil sur livhospital.com

  28. Arıcı Serdar, Şengiz Erhan Selma, ve diğerleri. "The Prognostic Importance of Microsatellite Instability Status in Turkish Stage II and III Gastric Cancer Patients who Received Adjuvant Chemotherapy." International Journal of Hematology and Oncology.

    Source : page de profil sur livhospital.com

  29. Sakin Abdullah, Şahin Süleyman, Atcı Muhammed Mustafa, ve diğerleri. "The effect of different treatment modalities on survival in elderly patients with locally advanced non-small cell lung cancer." Pulmonology.

    Source : page de profil sur livhospital.com

  30. Sakin Abdullah, Şahin Süleyman, Sakin Ayşegül, ve diğerleri. "Factors affecting survival in operated pancreatic cancer; Does tumor localization have a significant effect on treatment outcomes?" Northern Clinics Of Istanbul.

    Source : page de profil sur livhospital.com

  31. Sakin Abdullah, Yılmaz Ürün Yonca, ve diğerleri. "Factors Affecting Survival in Esophageal Squamous Cell Carcinoma: Single Center Experience." Northern Clinics Of Istanbul.

    Source : page de profil sur livhospital.com

  32. B. Uluslararası Bilimsel Toplantılarda Sunulan Bildiri Kitapları

    Source : page de profil sur livhospital.com

  33. Arıcı Serdar, Çekin Ruhper, Atcı Muhammed Mustafa. "ANDROGEN RECEPTOR STATUS IN TURKISH PATIENTS WITH HORMONE RECEPTOR POSITIVE LOCAL AND LOCALLY ADVANCED BREAST CANCER." ("6th Congress of the Mediterranean Multidisciplinary Oncology Forum" ve "3rd lnternational Congress on Oncological Sciences", Özet Bildiri/Sözlü Sunum)

    Source : page de profil sur livhospital.com

  34. C. Yazılan Ulusal/Uluslararası Kitaplar veya Kitaplardaki Bölümler

    Source : page de profil sur livhospital.com

  35. Atcı Muhammed Mustafa. "Küçük Hücreli Akciğer Kanserleri". KLİNİK ÇALIŞMALARLA ONKOLOJİDE HEDEFLİ TEDAVİLER içinde. Hipertıp Yayınevi.

    Source : page de profil sur livhospital.com

  36. Atcı Muhammed Mustafa. "Hormon Reseptör Pozitif Meme Kanserleri". KLİNİK ÇALIŞMALARLA ONKOLOJİDE HEDEFLİ TEDAVİLER içinde. Hipertıp Yayınevi.

    Source : page de profil sur livhospital.com

  37. Topçu Atakan, Beşiroğlu Mehmet, Atcı Muhammed Mustafa, ve diğerleri. "Second-line Therapy after Trastuzumab Failure in HER2-Positive Metastatic Gastric Cancer: A Real-life Data." Eurasian Journal of Medical Investigation (EJMI).

    Source : page de profil sur livhospital.com

  38. Ay Ersoy Seval, Tataroğlu Özyükseler Deniz, ve diğerleri. "Second Line Treatment Choice in Extensive Small Lung Cancer." Eurasian Journal of Medical Investigation (EJMI).

    Source : page de profil sur livhospital.com

  39. Arıcı Serdar, Çekin Ruhper, ve diğerleri. "The clinical importance of fibroblast growth factor 23 on advanced non-small cell lung cancer patients without druggable alterations in genes as EGFR or ALK or ROS1 Fibroblast growth factor 23 and non-small cell lung cancer." Eurasian Journal of Medical Investigation (EJMI).

    Source : page de profil sur livhospital.com

  40. E. Ulusal Bilimsel Toplantılarda Sunulan Bildiri Kitaplar:

    Source : page de profil sur livhospital.com

  41. Atcı Muhammed Mustafa. "KHDAK Tedavi Algoritması: Neoadjuvan, Adjuvan Tedavi Seçenekleri." (ULUSAL AKCİĞER SAĞLIĞI KONGRESİ, Özet Bildiri/Davetli Konuşmacı)

    Source : page de profil sur livhospital.com

  42. Dizdar Ömer, Kazaz Seher Nazlı, Atcı Muhammed Mustafa. "MULTİDİSİPLİNER TÜMÖR KONSEYİ: NONTÜBÜLER GİS TÜMÖRLERİ." (9. TÜRK TIBBİ ONKOLOJİ KONGRESİ, Özet Bildiri/Davetli Konuşmacı)

    Source : page de profil sur livhospital.com

  43. Atcı Muhammed Mustafa. "METASTATİK YUMUŞAK DOKU SARKOMLARINDA PAZOPANİBİN ETKİNLİĞİNİN DEĞERLENDİRİLMESİ: TEK MERKEZ DENEYİMİ." (5. Gençlerle Onkolojiye Bakış Kongresi, Özet Bildiri/Sözlü Sunum)

    Source : page de profil sur livhospital.com

  44. Hızal Mutlu, Bilgin Burak, ve diğerleri. "ALK MUTANT İLERİ EVRE KHDAK’DE BİRİNCİ BASAMAK ALEKTİNİB TEDAVİSİNİN ETKİNLİK VE GÜVENLİĞİNİN DEĞERLENDİRİLMESİ (TOG)." (8. Türk Tıbbi Onkoloji Kongresi, Özet Bildiri/Sözlü Sunum)

    Source : page de profil sur livhospital.com

  45. Özdemir Özlem, Zengel Baha, ve diğerleri. "HER2-POZİTİF MEME KANSERİ OLAN KADINLARDA NEOADJUVAN PERTUZUMAB VE TRASTUZUMABIN ETKİNLİĞİ VE GÜVENLİĞİ: TOG ÇALIŞMASI." (8. Türk Tıbbi Onkoloji Kongresi, Özet Bildiri/Sözlü Sunum)

    Source : page de profil sur livhospital.com

  46. Atcı Muhammed Mustafa. "KANSER HASTALARINDA TEDAVİ SEÇİMİNDE BEKLENEN YAŞAM SÜRESİNİN ÖNEMİ." (8. Türk Tıbbi Onkoloji Kongresi, Özet Bildiri/Sözlü Sunum)

    Source : page de profil sur livhospital.com

  47. Sakin Abdullah, Şahin Süleyman, Sakin Ayşegül, ve diğerleri. "PANKREAS KANSERİNDE SAĞKALIMI ETKİLEYEN FAKTÖRLER; TÜMÖR LOKALİZASYONUNUN TEDAVİ SONUÇLARI ÜZERİNE ETKİSİ VAR MIDIR?" (8. Türk Tıbbi Onkoloji Kongresi, Özet Bildiri/Sözlü Sunum)

    Source : page de profil sur livhospital.com

  48. Gürsoy Pınar, Tatlı Ali Murat, ve diğerleri. "Ekzon 18 Ve Ekzon 20 Mutasyon Pozitifliği Olan Hastalarda Tirozin Kinaz İnhibitörlerinin Etkinliği." (8. Türk Tıbbi Onkoloji Kongresi, Özet Bildiri/Sözlü Sunum)

    Source : page de profil sur livhospital.com

  49. Almuradova Elvina, Başoğlu Tüylü Tuğba, ve diğerleri. "SARKOMATOİD RENAL HÜCRELİ KARSİNOM TÜRKİYE GERÇEK YAŞAM VERİLERİ." (8. Türk Tıbbi Onkoloji Kongresi, Özet Bildiri/Sözlü Sunum)

    Source : page de profil sur livhospital.com

  50. Atcı Muhammed Mustafa. "Renal Hücreli Kanser Tedavisinde Nivolumab Tek Merkez Deneyimi." (4. Ulusal İmmünoterapi ve Onkoloji Kongresi, Özet Bildiri/Sözlü Sunum)

    Source : page de profil sur livhospital.com